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FACTORS AFFECTING HUMAN PERCUTANEOUS PENETRATION OF 
METHOTREXATE AND ITS ANALOGUES IN VITRO 
J. L. MCCUl.LOUCH, PH.D .. D. S. SN)'l)ER, PH.D .. C. D. WEINSTEIN, M.D .. A. FRIEDLAr-.D, M.D., AND B. STEIN 
Department of Dermatolo~y, Uniuersity of Miam i S chool of Medicine. Miami. Florida. U. S. A. 
Factors affecting the percutaneous penetration of methotrex.ate (MTX) and its analogues 
through excised human skin were studied. With application of 0.05 '" MTX solution to the 
epidermis. 0.07 ,* of the applied dose was recovered in the epidermis and less than O.OO5~ 
penetrated completely through the skin. The percent of drug which penetrated remained 
constant from O.05 ~ to 2.0o/r MTX and was also unchanged by increasing incubation 
temperature from 28°C to 37°C. Cellophane tape stripping of stratum corneum following 
drug- incubation removed essentially all the MTX that had been measured in whole 
epidermis. Binding of MTX was loca lized to the outermost layers of the st ratum corneum. 
With remo\'al of the stratum corneum prior to d rug incubation. 25 CT:f of the applied MTX 
penetrated through the skin. 
Various vehicles were tested 10 determine their effect on MTX percutaneous absorption. 
Dimethylsulfoxide (800,;). dimethylacetamide (25~). or retinoic acid (0.1 W) had no effect on 
penetration . Maxi mum enhancement of penetration by 25-fol d and 143- fold was obtained 
with retinoic acid (saturated solution in aqueous ethanol) and C-IO-methylsulfoxide (2.5<':; 1. 
res pectivel)' . The penetration of lipid-soluble deri\'atives of MTX was also tested. The 
compound that penetrated best was the dimethyl ester of dichloro-MTX with a 3-foJd 
increase in penetration over MTX. 
The folic acid antagonist methotrexate (MTX) 
is an important syste mic chemotherapeutic drug 
used for the treat ment of extensive psoriasis 11-:1]. 
Although MTX is effective sy!' temicall.\·. its u!'e 
topically has been clinieally unsuccessful [4- 81. 
Since MTX is a water-soluble drug, it \ ... 'ould not be 
expected to markedly penetra te through the stra-
tum corneum barrier . One way to impro\'e the 
penetrat ion of MTX would be to increase the 
lipophil ic character of the moiC'('uie . Alterations in 
\'ehicle would be another approach to enhance 
penetration . The present investigation was there· 
fore init iated to deter mine the percu taneous ab-
sorpt ion of se\'eral lipophilic e:-ters of MTX and to 
e\'aluate \'ehide effects on MTX penetration. 
MATEHIALS A,\;D METHOD~ 
Methotrexa te tMTX l and :r.S·. dichlorome thotrex8te 
(OrM) were obtained fro m L{'derl e Labora tor ies.. Pearl 
Ri\'N . :--: . Y .. throug-h the ('ou rle:o;y of Drs. J . M. Smith and 
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G. M. Siej!er. These drugs were pu r ified by column 
chromalo~ raphy on DEAE-cellulose 191 prior 10 use . The 
dialkyl ester:- of MTX and Oe M were synthesized and 
provided to us by Dr. D. G. Johm~. :\'ational Cancer 
Ins titute . .\'ational Institutes of Health. Bethe!Oda. Mary-
land. The purity o j the ester!" was checked b:-' ascendinj! 
ch romatography on thin -layer cellulose plates in ethanol : 
water:acetone (70:10:51. 
Methotrexate t3'.5·.9! n)·'H ) sodium salt 1250 meil 
mmole) was purchased fro m Amersham/Searle Corp . a nd 
prior to u!-e was purified by ch romalOj!'raph~' o n thin· 
la,ver cellulose plates in 0.006 M potassium phosphate 
buffer. pH 6.0, C-IO-Methylsulfoxide 1('·lO-MSO) was 
prepared by one of us (D.S.S . 1. Dimethylsulfoxide 
(DMSO ) wa~ purthased from Sij!ma. dimethylact'lamide 
(DMAC) from Baker. all tron~·re-tinoic acid from Eas\ -
mall Kodak. and Emulphor EL-610 from the GAF Corp. 
Diffu ... ion Stu dle.~ 
Cell preparation. Clinically normal. full·thickness hu-
man :okln was obtained 8t autopsy from the a nterior 
abdomen near the midline . Subcu\aneou~ fat was ca re· 
fully removed with scissors. The skin was washed quickl.\· 
with mild deter~ent. rim;;ed. and blolled dry. The skin 
wa!' cu t into separate spe('imens ( -1 ~ 4 rm) fo r each 
diffus ion chamber. Prior 10 u:;e the electrical resistan(,e of 
each specimen \\'as measu red to ascertain the intactness 
of the epidermal barrier. This measurement pro\'ed to be 
essential since a low resi::.tance in the skin indicated 
breaks or an inferior barrier which would make it 
uns.uitable for diffusion s tudies. The 5kin specimens were 
mounted in a glas~ diffusion cell. dermal side down. 
co\'ering an O-r ing:. 8s pre\' iously desc ribed [10 I. The 
epide rmal surface area of sk in exposed to the penetrant 
was 4.15 cm~. One milliliter of a solution containing: drug 
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was applied to the epidermal surface of the skin . In 
experiments employing tritiated MTX. approximately 
25--50 p Cj of MTX were applied 1.0 each chamber in the 
presence of cold MTX to ~i\'e the approprial e final 
concentration. The dermal reservoir contained a stirr ing 
bar and was filled with a solution containing 0.01 M Tris . 
pH i .5, O.9 tt NaC! , and 100 ~f.!/ml gentamicin. Diffu!'ion 
cells were incubated with constant stirrinJl: for 20 hr in the 
dark at room lemperature (28°C) or 813"j °C. A minimum 
of 3 diffusion cells was run for control and each le:-! 
condition except where indica ted . 
After the incubation period, the lest solution was 
removed and the epidermal surface was rinsed 3 times 
with the vehicle in which the dru~ being tested was 
dissolved . This process effectively removed all d ruJ{ 
which had not penetrated int o the i;i tratum corneum. The 
skin specimens were blotted dry and again checked for 
elecnica l resistantt' o Only experiments in which the skin 
maintained 8 high resi::tsnc{' are reported here . The 
epidermis was separaled by heating the s kin fo r I min on 
a hot plate at 60°C. MTX was extracted from the 
epidermis and dermis ut ili zi ng the technique desc rihed 
by Werkhei!'er et 81 [II]. The stratum corneu m was 
removed where indicated by repeated st r ipping with 
cellophane tape until the skin ~listened. 
Considerable biolol!ic va riat ion exists between differ-
ent skin speci mens with regard to percutaneous absorp-
tion. When a co mparison is made among MTX analoJ!ues 
and among variou!= vehicles. the results a re expres:,ed 
TABLE I. EIIE-'cl 01 met hotrexate concent rat ion on 
percutanenus ab ... orpt ion 
Metholrexate 
concentrat ion D 
(CY I 
0 . 05~ 
O.5e 
1.0' 
2.0' 
c;y of Applied cou ntS recovert'd 
\ A l>f:'ra,l!{' :I:. S. E.) 
Epiderm j~ 
0.070 : .005 
0.094 r .009 
0.067 r .003 
0.04; ::: .00:2 
Saline 
0.004 : 0.00 1 
0.002 : 0.000 
0.£X)2 r 0.001 
< 0001 
CI ['H jMTX ap plied and incubated for 20 hr at 3i Cl C 
" Mean of 12 cells run on ;l skin specimens 
C Mea n of 3 cells on the same skin specimen 
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relal ive lO 8 MTX control sample run in lriplicale on the 
same skin specimen. 
A ..... ·wy lor dru/! penetration. Triliated MTX was used 
a nd lhe quantity of dru~ in the epidermis and in the 
de rmal (' hamber sal ine was determined by liquid scintil -
la! ion count i n~ . ThE." data are expressed as percen t 
recovery of the applied dose. 
Unlabeled MTX and lipophilic MTX analogues were 
used in the experiments reported in Tableo,;. IV and V. The 
concentrations of the unlabeled drugs were determ ined 
by t he d ihydrofolat e reductase assay prE'v iou !oi ly de!=c ribed 
in detail by Berlino a nd Fisher ]12]. The dih ydrofolu te 
reducta~e used for these aS5ays was parlially purified 
from rat liver by ammonium sulfate fractionation accord -
in~ to the procedure of Baker and Loureus [13]. The lower 
limit of!:Oens itivityofthisass8yis:2 . 10 IU Minlheassay 
('uvellE' . This sensitivity allowl'> determ ination of minimal 
MTX levels of 1.8 ng in the tot a!!(lwe r snli ne solution . 
AururadioKraphy 
Following a ~() - hr incuba t ion with tr itw ted MTX. a 
portion of the skin was pro{'e~),ed by standa rd autoradio-
graphic- t€'chnique!- [l 4 J a nd another portion 01 the skin 
was frozen quidl .... a nd sectioned a t 10 ~ wtth 8 c ryo~ta t . 
Frozen ~ections were lransferr€'d to ("old .:.Iide~ and 
desiccated at - 20ClC. Slides were coated with Kodak 
:--':TH-l emuh.ion using a dry loop I€'chnique :-Imilar ICI 
that 01 M ille r. Stone. and Prescot! [IS] . The !>Iide:- were 
developed 6 week!' later. :-tained with H &. E. and 
examined lor the distr ihution oj :,ih-l'r grain~ . 
RES LILTS 
Pen etration of M et hotrexat e 
\-Vith application of a 0.05 f ·( aqueous solution of 
tr itiated MTX to the epidermis. 0.07 "; of the 
applied dosE' (O. :l) ~g ) W 8:-- reco\-ered in the epider. 
mis and less than O.OO.i ("' fO.025 .ugJ had penE' traled 
completely through th e dermis t o be recove red in 
the saline contained in the lower dermal cha mber 
(Tab . I). Similar resul ts were obtained with unla-
beled MTX ulilizing the dihydrofolate red uclase 
assay in Table I\" . :\0 siJmifican t increase in th e 
percen t penetration was obtained by increa~ing the 
incubation temperatu re from :!R o(' to :rjOc. 
TABLE n. Localization 01 [ ~H Jmelho l rerale In skin 
Experiment" 
Slratum corneu m 
in tact 
Stratum corne um 
re moved after 
experiment 
Slratum corneum 
removed prior lo 
experiment " 
St ratum 
corneum 
0.001 
~.OO3 
"; of Applied l'ount ~ recovered 
(At ('r a,l.' f' .I- S.E .1 
Epidermll' 
O.Oil 
" .IX):! 
"'- 0.001 
0.44 
Dermi ... 
. 0.001 
. 0.001 
2.3 
II. 0.0:') % of aqueous solu tion of [JH ]MTX appl ied and incu bated for 20 hr a1 28 D C 
" One cell only 
SlIluU' 
0.004 
:1... 001 
0.004 
:1..001 
25.2 
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I< U",,9lfl Of S lIlIl> S 
F'u ;. 1. Localization of triliated methotrexate in stra~ 
1um corneum by repeated cellophane tape s tr ipping . 
A B 
.. 
FIG. 2. AUlOrad iogra phs of skin following 20-hr expo-
sure 10 t rit all ed methotrexate us mg L4.1 standard tech-
niquE' and IBl frozen sect ion technique. Silver l!rain~ a re 
loealizE'd in the st ratum co rneum . 
Localization of M eth otrex ate in Skin 
In Ta ble II are summari zed the result s of an 
experiment in which the localization of tritium-
labeled MTX in , kin was d.,ermined bv liquid 
scintillat ion count ing . Essem iaHy all of the MTX 
present in whole epiderm is was removed by cello-
phane tape st ripping. a technique which remm'es 
t he stratum ('orneum. A!' shown in Figure 1 the 
tritiated MTX wa ::; locali zed to the outermost 
layers of th E' stratum corneum since most of the 
radioacti\' ity was remo\'ed with :3 or -t strips. The 
binding of MTX to the outermo5;t la~'er5 of the 
slrat urn corneum was also confi rmed b~' frozen 
section a UlOradiograph~' (Fig. '28). The t ighlness of 
this binding to the st ratum ('orneum was also 
indicated by a similar gra in pattern wh ith was 
obse r .. ed afte r us ing standard autoradlographic 
t.echniques. " 'hich easil~' ext-ract non bound com-
pounds ( Fi ~. 2A l. 
Removal of the stratum corneum prior 10 appli, 
cat ion of 13H J MTX resulted in rE'co\"er~' of 25 1'( of 
the applied MTX in the saline. demonstratin~ l hal 
the intact st ratum corneum is an effecti\'e barrier 
to MTX diffusion. 
Effect of Vehicle on MTX Penetrat ion 
Various vehicles were examined to determine 
their effect on MTX percutaneous absorption 
PERCl1TANEOLlS PE!'-IETHATIOf\' Of METHOTREXATE 
TABLE III . Effect of vehicle on [J HJm ethotrexate 
penetration 
Experimental 
vehicle 
DMSO t80 <;; )' 
DMAC 125 'l1 )' 
C· IO·MSO (2.5'11 I' 
Retinoic acide 
Ratio of l·H ]methotrexate 
penetration in experimental 
vehicle/st.a ndard vehicle" 
(A vera~e ± S.E.1 
Epidermis 
0.520::: .06 
0.20 ~ .02 
7.90 ~ .4" 
Saline 
1.80 ~ .58 
0.80 ~ .23 
141 ~ 28 
(C. I (fr in95 '1i ethanol ) 1.12 ::t; ,08 
Retinoic ac id lr 
1.29::t:.47 
(Sa turated so lu -
lion in .=)() '/ aque-
QUS el hanoi) 
3.30::::- .1 J 25 . 10::t: 8.90 
105 
a Standard vehicles: O' H ,O: (' 95~ ethanol: d 500/r aque· 
ou !> el hanoi . All samples contained 0.05(( MTX and were 
run at 37 ac for 20 hr ex cept ret inoit acid. O. 1 ~ , (28 DC). 
(Tab . UI). OM SO (80'; ) increased penetralion 
l.8-fold with no increase of drug: in the epidermis, 
OMAC (25 C; I and retinoic acid (0. 1'; I had no 
enhancing effect on penetra tion . Retinoic acid 
(saturated solution in 50 C:: aqueous ethanol) en-
hanced penetration 25-fo ld and increased the con-
centration in the epidermis 3-fold . 
A maximum enhancement of MTX penetration 
of 140·fold was obtained with C·IO·MSO (2.5 '; I. 
This al~o ga\'e an increase in epidermal MTX 
concentration of approximately 8-fold. :\!o increase 
in MTX penetration was obtained with 1.0% 
C·IO· MSO. 
Penetration of Lipid· oluble Analogues of MTX 
The percutaneous penetration of MTX ana-
logue!' which are severa lfol d more lipid soluble 
than MTX [16 ] was examined . (Tab . !VI. Of the 
compou nds tested the most eHeeli\'e compound 
was the climet hylester of dichloromethotrexale 
(DeM ) with a 3-fold increase in penetration Q\'er 
MTX and a l-t-fold increase in concent ra tion in the 
E'pidermis. 
A time study of the penetration of the dimethyl-
ester of OCM (Tab . VI indicates that increasing 
the comact time between skin and drug from I to 
24 hr does nut increase the drug's percutaIleuus 
absorption . There does appear to be a slight 
increase in epidermal content of the drug between 
6 and 2-t hr of contact time , 
OIsn·SSIOl' 
The present im'esligat ion was carr ied out to 
stud~' the percutaneous penetrat ion of MTX in 
human skin in vit ro and to examine \'arious factors 
which mighl enhance drug penetration . Other 
investigators have reponed percutaneous penetra· 
Lion of MTX in vitro. rangi ng from 0 to 24 c-c ion 20 
hr [17]. The presenl experiment.s using bOl h cold 
and radioact ivel)' labeled MTX failed to detect 
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TABLE IV. Percutaneous penetration of various folic acid antagonist /,>, 
Om!!", 
MTX 
MTX -Dimethylester 
De M 
DCM-Dimethy lester 
Epidermis 
1.0 
14 .53 ± :L ~~fl 
1.14 ± . 19 
14 .Si :to 1.08 
Rat.io of dru~!MTXO 
Dermis Saline 
1.0 1.0 
10. 14 .:l. 5.24 j .22 ± .28 
1.25 ± .30 1.2"; ::t: .4 2 
2. 18 :1.. .37 3.04 1 .~3 
a 0.05% solution of drug applied to epidermal chamber and incubat.ed for 20 hr at 28 °C. The vehicle is H ~O:elhano l : 
Emulphor EL-620:DMSO (89:5:5:1) adjusted to pH 7.5. Drug concentration determined by dihydrofolate reductase 
assay. 
o Average (±S. E. I of [) different !'k in specimen!' 
TABLE V . Time stud,' of percutaneow, p('nf'lrat iorl of 
DCM-dim ethylester" 
T iml' 
Ihr J 
1 
6 
24 
rt of Applied dru~ rel~o\'ered: 
Epidermis 
0.20 % .02 
0.25 ~ .04 
0.39 ::t: .05 
0.012 ":%. .006 
0.0 1:2 :1. .()()4 
0.0 14 1 .009 
"o.o.=) t;{- aqueous solut ion of dru~ applied to epidermal 
chamber and incubated at 28 °('. Drug concen tration 
determ ined by dihydrofol at€ r€'duclas€ assay. 
I> Avera~e (:%o S.E. ) of 4 cells (6 hr ): and 6 cells 124 hr l. 
Two separate skin specimens were c\·aluated . 
any significant penetrat ion under several cond i-
tions. such as var .... ing concentration or tempera-
tu re. 
There are two considerations with rega rd to the 
experimental techn ique employ·ed in the presem 
study which could accOunt fo r the discrepanc .... 
between these data and those previously reported . 
J. The commercially obta ined tritiated MTX 
was fou nd by thin-layer chromat ography to con-
tain approximately 40 to 60!ft impurities. In the 
present study. it was therefore considered essential 
to remove these radioacti\·e impurities or break-
down products which might penetrat e more readily 
than MTX. Similar purifications were also carr ied 
out with nonradioactive compounds. si nce these 
impurities might penetrate more readily than the 
pure compound, inhibit dihydrofolat.e reductase. 
and thus give falsely high values for drug penetra-
tion. 
2. Measurements of electrical resista nce of skin 
samples were employed in the present study bot h 
before and after incubation to ascertain the intact -
ness of the epidermal barr ier . This measurement 
ensures that on ly skin sp~cimens with intact. 
nondisrupted barriers are used . During t.he cou rse 
of these studies severa l skin specimens had to be 
eliminated on the basis of t heir low resistance. This 
resistance measurement is, therefore, essential for 
obtaining meaningful data, s ince skin with a low 
resistance would yield falsely high values for pene-
tration . 
When MTX was applied to the skin in an 
aqueous vehicle. the drug ex tracted from the 
epidermis was found to reside entirely in the ou ter 
su perficial layers of the stra tum corn eum. There 
appears to be a \·ery tight binding of MTX to the 
strat urn corneum since it was not t.ot ally removed 
by standard autoradiographic techniq~es which 
remove nonbou nd compounds. 
One approach to enhancing drug penetration is 
alterat ion of the vehicle which pla.\·s a crit ical rol e 
in the release and part it ioning of the drug LO the 
skin surface . Anum ber of organic solvent.s such as 
dimeth~' lsu l fo xide and dimethylacetamide ha"e 
been reported to enhance the penet rat ion of drug!' 
[17- 19]. How,,·er. in the present study these 
agents gave only a minim a l increase in MTX 
percutaneous penetration. with no increase in the 
epide rm al drug concent ration. 
The subst itution of one met hyl grou p of DMSO 
with a longer-cha in al kyl group gives rise to a 
family· of sulfoxides th at are stable. nonionic su r-
face-active agents /lOJ. C-IO- MSO at low concen· 
trations has been reported to faci lit ate the penetfi'l -
t ion of wat er-solubl e d rugs into the skin [10 [. In the 
present study. a maximum enhancement of MTX 
penetrat ion of 140-fold was ohtained with 2.5 c,( 
C- IO- MSO . With this co ncentration ofC-lO- MSO. 
a quant ity of 0.004 m~ of MTX was extrac ted from 
the epiderm is {4.15 cm 2 surface a rea l. gi\·ing a 
concentration of 0.001 mg/cm 2 . In view of previous 
data by Weinslein et al [20[ sh()win~ Ihat an 
intradermal dose of MTX of 0.00 1 mg/O. IO ml 
results in a 50% inhibition of D!'A synthesis in 
psoria t ic cells. it would seem that these epidermal 
MTX co ncentrations obtained with C- lO- MSO are 
approaching levels sufficient for pharmacologic 
activi ty at t he cellula r level. 
Since MTX is a water-soluhl e compound wilh 
minimal lipid solubility. one would not ant ici pate 
extensive percutaneous penetrat ion . One means of 
improving the penetration of MTX would be to 
increase th e lipophilic character of the molecule . 
We attempted to decrease the ionization of the 
molecule by lowering the pH . However, it was not 
possible to keep the MTX in solution below pH i. J. 
Another means of increasing the lipophil ici ly of the 
molecule is t.o esterify the carboxyl groups. Various 
lipophilic esters ofMTX and dichloromethotrexate 
have previously been reported to be more effective 
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than MTX as inhibitors of deoxyruridine incorpo-
ration into DNA in normal (21,22 \ and psoriatic 
skin \22). In the present study these lipid -solu ble 
analogues penetrated more readily t.han did MTX . 
Relative to MTX, the increased permeability of 
these esters and also their increased inhibitory 
activity in psori atic epidermis [22 J warrant investi-
gation of these lipid-soluble analogues for the 
topical treatment of psoriasis. 
The results of the present study suggest th at one 
of the possibl e reasons for the clinical ineffective-
ness of topical MTX in psoriasis may be the lack of 
sufficient epiderm al penetration. Factors enh anc-
ing epidermal penetration of MTX or its analogues 
as described here, may play an important role in 
the development of future topical chemotherapy of 
psorias is. 
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